MedShift Marketplace, the aesthetic industry's #1 resource for premium aesthetic products and supplies, announced it has ...
FibroBiologics files a new USPTO patent covering its fibroblast-based platform for disc repair, cartilage restoration, and ...
The novel radiotracer ¹⁸F-FAPI-RGD in PET/CT scans shows potential for diagnosing ILD in connective tissue disease patients by highlighting fibroblast activation and tissue remodeling. Patients with ...
Background Intestinal fibrosis, a hallmark complication of Crohn’s disease (CD), frequently progresses to stricture formation ...
Platform Poised to Expand into Joint and Cartilage RepairHOUSTON, Dec. 10, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage ...
Understanding Varicose Veins Varicose veins arise from a chronic circulatory disorder called chronic venous insufficiency ...
Avacta reported new pharmacology data on its second oncology asset, FAP-Exd (AVA6103), on Thursday, showing sustained tumor ...
A permanence-first strategy aligns with modern health trends: addressing root causes, building tissue resilience and reducing long-term dependency.
2026 is about smarter, more natural-looking skin solutions: Expect pared-back routines, personalization, and regenerative ...
The aggregate gross proceeds to the Company from the offering were approximately $1.7 million, before deducting the placement agent’s fees and other offering expenses payable by the Company. The ...
Triage Plus was designed to detect mRNAs and DNA single-nucleotide variants from fibroblast growth factor receptor 3 and telomerase reverse transcriptase genes associated with bladder cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback